UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, focusing on innovative treatments for severe diseases in immunology and neurology.

About

Related projects

Projects

Learn more

NEMO

    R&D Advanced Therapies Biopharma

En cours

Learn more

GTRP-DIAT

    R&D Advanced Therapies

En cours

Learn more

Targetum

    R&D Biopharma

Terminé

Related news

News

Learn more

UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder

    Press release

27.06.2025

Learn more
_UCB8015p_

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

    Press release

12.06.2025

Learn more

UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences

    Press release

19.05.2025

Related jobs

Jobs

Learn more

Talent Operations Advisor – Payroll Specialist

Braine L'alleud | Fixed contract - Full time | Human resources

Learn more

Biomanufacturing Manager – Media & Buffer

Braine L'alleud | Fixed contract - Full time | Manufacturing & engineering